Official UK procurement notice
Provision of Consultant Led, Elective Care Services - Rheumatology, Gastroenterology, Endocrinology
Authority: NHS STAFFORDSHIRE AND STOKE-ON-TRENT INTEGRATED CARE BOARD (Central government)
What is being bought
Published requirement descriptionNHS Midlands & Lancashire Commissioning
Support Unit (MLCSU) are acting on behalf of the
Commissioner, NHS Staffordshire and Stoke-on-Trent Integrated Care Board (SSOT ICB). The ICB followed the Direct Award B process in accordance with the Health Care
Services (Provider Selection Regime) (PSR) 2023
for the Provision of Consultant Led, Elective Care Services - Rheumatology, Gastroenterology, Endocrinology, with
CPV Code 85112200-9 (Outpatient care services).
CPV: Outpatient care services
The lotProcurement structure
single lot · no lot value publishedLot #1Contract Award Notice for Direct Award B Process for the Provision of Consultant Led,…Awarded
Contract Award Notice for Direct Award B Process for the Provision of Consultant Led, Elective Care Services - Rheumatology, Gastroenterology, Endocrinology
for Staffordshire and Stoke - on - Trent Integrated Care Board (ICB)
NHS Midlands & Lancashire Commissioning Support Unit (MLCSU) are acting on behalf of the Commissioner, NHS Staffordshire and Stoke-on-Trent Integrated Care Board (SSOT
ICB).
The ICB followed the Direct Award B process in accordance with the Health Care Services (Provider Selection Regime) (PSR) 2023 for the Provision of Consultant Led, Elective Care Services - Rheumatology, Gastroenterology, Endocrinology with CPV Code 85112200-9 (Outpatient Services).
The Direct Award B process involves awarding a
contract to provider(s) where the services offered by the Provider are deemed Patient Choice, and the number of providers is not restricted by the relevant authority. The Provider has undergone the ICB Accreditation Process and passed all requirements.
The contract is dated 01 July 2025 to 31 March 2027. The estimated lifetime value of the contract is £748,021 based on the ICB approved Indicative Activity Plan but excluding Endocrinology which will be determined in year. These are new services with an existing provider.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 6 Aug 2025, 16:43 BST
- Last source update
- 6 Aug 2025, 16:43 BST
- Authority reference
CMT-1362- FTS notice number
2025/S 000-046685- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0582dbFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
Health Care Services (Provider Selection Regime) Regulations 2023 - Direct Award B
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. Award decision makers: Chief Delivery Officer Approved 16 June 2025 Approval of the Provider was completed via the ICB Accreditation process and subsequently by the Procurement Advisory Panel on 16 Jun 25. The MDT and POG agreement and approval processes seek for any Conflicts of Interest and, if declared, these are documented and managed accordingly to SSOT ICB policy. Any persons with known or declared Conflicts of Interest were excluded from the decision making process. No conflicts of interest were declared.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Medefer LimitedThe Provision of Consultant Led, Elective Care Services - Rheumatology, Gastroenterology, Endocrinology | £748,021 † | — | Awarded |
Contracts
The Provision of Consultant Led, Elective Care Services - Rheumatology, Gastroenterology, Endocrinology · Medefer Limited
- Signed
- 1 Jul 2025
- Value
- £748,021
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
Bidders & participating suppliers
1 commercial party on the notice- MEDEFER LIMITEDAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.